viernes, 1 de diciembre de 2023

SAMHSA Collaborates with Federal Partners to Understand Buprenorphine Availability in Pharmacies SAMHSA, DEA, and OASH Host Town Hall with Pharmacists about Opioid Overdose Prevention

https://www.samhsa.gov/medications-substance-use-disorders/pharmacist-verification?utm_source=SAMHSA&utm_campaign=46bba620bb-EMAIL_CAMPAIGN_2023_10_26_06_17&utm_medium=email&utm_term=0_-46bba620bb-%5BLIST_EMAIL_ID%5D#buprenorphine-access

No hay comentarios: